FdaApplication

BLA 125397

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNew York Blood Center, Inc.
application_typeBLA
approval_date2011-11-10

Products (1)

ProductActive ingredientStrengthDosage form
HEMACORD—5 X 10E8 TOTAL NUCLEATED CELLS WITH AT LEAST 1.25 X 10E6 VIABLE CD34+ CELLS UInjection

1 product